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DAN Directs Endolymphatic Sac and Duct
Outgrowth in the Avian Inner Ear
Lisa M. Gerlach-Bank, Amanda R. Cleveland, and Kate F. Barald*
Bone morphogenetic proteins (BMPs) are expressed in the developing vertebrate inner ear and participate in inner ear
axial patterning and the development of its sensory epithelium. BMP antagonists, such as noggin, chordin, gremlin,
cerberus, and DAN (differential screening-selected gene aberrative in neuroblastoma) inhibit BMP activity and
establish morphogenetic gradients during the patterning of many developing tissues and organs. In this study, the
role of the BMP antagonist DAN in inner ear development was investigated. DAN-expressing cell pellets were
implanted into the otocyst and the periotic mesenchyme to determine the effects of exogenous DAN on otic
development. Similar to the effects on the inner ear seen after exposure of otocysts to the BMP4 antagonist noggin,
semicircular canals were truncated or eliminated based upon the site of pellet implantation. Unique to the DAN
implantations, however, were effects on the developing endolymphatic duct and sac. In DAN-treated inner ears,
endolymphatic ducts and sacs were merged with the crus or grew into the superior semicircular canal. Both the canal
and endolymphatic duct and sac effects were rescued by joint implantation of BMP4-expressing cells.
Electroporation of DAN antisense morpholinos into the epithelium of stage 15–17 otocysts, blocking DAN protein
synthesis, resulted in enlarged endolymphatic ducts and sacs as well as smaller semicircular canals in some cases.
Taken together, these data suggest a role for DAN both in helping to regulate BMP activity spatially and temporally
and in patterning and partitioning of the medial otic tissue between the endolymphatic duct/sac and medially derived
inner ear structures. Developmental Dynamics 229:219–230, 2004. © 2003 Wiley-Liss, Inc.
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INTRODUCTION
In most vertebrates, including the
chick, the complex process of inner
ear formation begins with the spec-
ification of an epithelial placode
that thickens and invaginates to
form an otic cup. As the embryo ma-
tures, the otic cup closes to form the
otic vesicle. The otic epithelium un-
dergoes a series of poorly under-
stood cellular movements to form
the complex three-dimensional
structure of the mature avian inner
ear (Li et al., 1978; Bissonette and
Fekete, 1996). The posterior semicir-
cular canal (PSC) and the superior
semicircular canal (SSC) develop
from the superior dorsal region of the
otocyst while the lateral semicircular
canal (LSC) is derived from the more
ventral region. The endolymphatic
duct (ED) and sac (ES) emerge from
the dorsomedial region of the oto-
cyst. The cochlear duct elongates
from the ventromedial region (Li et
al., 1978; Bisonnette and Fekete,
1996).
Many genes have important roles in
these processes, including transcrip-
tion factors and growth factors. Bone
morphogenetic proteins (BMP), mem-
bers of the transforming growth fac-
tor- superfamily of growth factors
that includes Drosophila decapen-
taplegic (dpp), are expressed in the
inner ear and are believed to direct
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the axis formation of the developing
otocyst (Wu and Oh, 1996; Gerlach et
al., 2000; Gerlach-Bank et al., 2002;
Thompson et al., 2003). BMP7 is ex-
pressed throughout the stage 17 otic
vesicle except for a small medial–ven-
tral patch. BMP5 and BMP4, ex-
pressed earlier in anterior and poste-
rior placodal epithelial patches, are
limited to an anterior and a posterior
focus in the otic vesicle while at later
stages BMP4 is expressed in the pre-
sumptive sensory epithelium (Oh et
al., 1996; Wu and Oh, 1996).
Many BMP antagonists have been
identified, including noggin, chordin,
gremlin, cerberus, and DAN (differ-
ential screening-selected gene ab-
errative in neuroblastoma). We pre-
viously demonstrated that noggin
was expressed in the periotic mesen-
chyme surrounding the otocyst
(Gerlach et al., 2000). Exogenous
noggin introduced at the BMP4 foci
of the otocyst, blocking the activity
of BMP4, produced specific canal
abnormalities. Blocking BMP4 activ-
ity at the anterior focus generated
abnormalities in the anteriorly de-
rived canals, whereas interfering
with BMP4 activity at the posterior
focus prevented normal posterior
semicircular canal development
(Chang et al., 1999; Gerlach et al.,
2000). Addition of exogenous BMP4
along with noggin prevented the
noggin-mediated inner ear abnor-
malities as long as the two protein
sources were implanted close to
one another (Gerlach et al., 2000).
This finding suggested that the nog-
gin expressed in the periotic mesen-
chyme could act to restrict the ac-
tivity of BMP4 to the otic epithelium.
The question remained whether
other BMP antagonists also acted to
limit BMP4’s patterning activity.
In this study, we investigated the
BMP4 antagonist DAN, which we
previously demonstrated was ex-
pressed in the medial otic epithelium
throughout avian inner ear develop-
ment (Fig. 1; see also Gerlach-Bank
et al., 2002). DAN, first identified in
transformed rat fibroblasts (Ozaki
and Sakiyama, 1993), has been iso-
lated subsequently in mouse, Xeno-
pus, human, and chicken (Enomoto
et al., 1994; Ozaki et al., 1996, 1997a;
Hsu et al., 1998; Ogita et al., 2001;
Gerlach-Bank et al., 2002). This se-
creted protein is structurally related
to cerberus and gremlin and is ca-
pable of antagonizing BMPs in em-
bryonic explants (Stanley et al.,
1998; Hsu et al., 1998).
Exogenous mouse DAN protein
was introduced into avian inner
ears by implantation of mouse DAN
(mDAN) -producing Chinese ham-
ster ovary (CHO) cells. The mouse
and chick DAN homologues share
76% amino acid identity. Morpho-
logic analysis of exposed ears indi-
cates that semicircular canals are
affected in an implantation site-
specific manner, as was seen in the
noggin implantation experiments
(Gerlach et al., 2000). Unlike the
noggin experiments, however, ex-
posure to exogenous DAN also
caused the endolymphatic duct to
grow toward or fuse with the SSC or
with the crus. In normal otic devel-
opment, no connection between
the endolymphatic duct and sac
and the SSC is observed at any de-
velopmental stage. Joint implanta-
tion of mDAN-expressing cells with
BMP4-expressing cells rescued this
abnormal inner ear phenotype. Im-
munohistochemical analysis of the
treated otocysts’ hair cells demon-
strated no obvious alteration in the
shape or size of the sensory epithe-
lium if the ampullae or basilar pa-
pilla were not abnormal.
Finally, in ovo electroporation of
the otocyst, where DAN is ex-
pressed, with a chick DAN morpho-
lino antisense oligonucleotide gen-
erated enlarged endolymphatic
sacs compared with the sacs that
developed from otocysts electro-
porated with control morpholinos,
including a sense morpholino, or
not electroporated. The inner ear
sensory patches in morpholino-
treated inner ears appeared nor-
mal. Taken together with the DAN
exposure data, these data suggest
a role for DAN in partitioning the
medial otic tissue between the en-
dolymphatic duct and sac and the
remainder of the medially derived
inner ear structures, although the
proteins with which DAN interacts
to affect the development of these
structures remain unknown.
RESULTS
Exogenous DAN Alters Gross
Inner Ear Morphology
mDAN-producing CHO cells, BMP4-
producing CHO cells, or untrans-
fected CHO cells were implanted
into or next to chick otocysts to de-
termine their effects on inner ear
morphology (Fig. 2). Cell pellets con-
taining 1,000 cells were made of
each cell type. After overnight cul-
ture, these pellets contained an av-
erage of 2,937  41 (SEM) cells.
Western blot quantification of V5-
tagged mDAN demonstrated that
each pellet produced approxi-
mately 52.7 pg of tagged protein
per 24-hr period.
Five types of pellet implantations
were performed. Pellets were inserted
in the anterior, posterior, dorsal, or
ventral regions of the periotic mesen-
chyme or in the center of the otocyst
(Fig. 2A). The anterior and posterior
implantation regions correspond to
the anterior and posterior BMP4 ex-
pression foci in the developing oto-
cyst (Wu and Oh, 1996; Gerlach et al.,
2000). The implantations were per-
formed between stages 11 and 19
(Hamburger and Hamilton, 1951; em-
bryonic day [E] 1 and E2), and the
inner ear morphology was analyzed
between E5 and E10 by paint filling
(Martin and Swanson, 1993). Implan-
tations were performed on the right
inner ear, with the left ear serving as
an internal control.
Control implantations, which con-
sisted of sham implantations (n  7,
Fig. 2D) or untransfected CHO cell
Fig. 1. DAN (differential screening-se-
lected gene aberrative in neuroblastoma)
expression in the medial otic epithelium of
a stage 16 embryo. A, anterior; hb, hind-
brain; L, lateral; o, otocyst. Scale bar  100
m.
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Fig. 2. Paint fill analysis of DAN (differential screening-selected gene aberrative in neuroblastoma) -exposed inner ears. A: Diagram of
pellet implantation sites. Shaded regions represent the areas covered by each implantation category. B: Posterior view of stage 20 inner
ears. The left ear was untouched. The right ear was exposed to a mouse DAN (mDAN) -expressing cell pellet. The endolymphatic duct (ed,
ED) is shorter than the normal left ED and is partially merged with the main body of the otocyst. C: Posterior view of stage 26 inner ears.
The mDAN-exposed right inner ear has a shorter and thicker ED than the left control ED. D: Normal stage 36 inner ear. E: A stage 36
mDAN-exposed inner ear with the ED joined to the superior semicircular canal (SSC, arrowhead). F: An mDAN-exposed stage 36 inner ear
missing the SSC but with a nub (asterisk) growing from the endolymphatic sac (es, ES) toward the superior ampulla (SA). G: An
mDAN-exposed stage 36 inner ear missing the SSC, having a reduced lateral semicircular canal (LSC) and an ES growing laterally toward
the crus. H: A stage 36 mDAN-exposed inner ear with no SSC or LSC and an abnormally shaped ES/ED partially merged with the crus. A,
anterior, CD, cochlea; D, dorsal; LA, lateral ampulla; P, posterior; PA, posterior ampulla; PSC, posterior semicircular canal; S, saccule; U,
utricle; V, ventral. Scale bars  100 m in B (applies to B only), in D (applies to C,D), in E (applies to E,F), in G (applies to G,H).
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pellet implantations (n  15) resulted
in normal inner ear phenotypes at all
stages examined. The inability of
CHO cells to alter inner ear morphol-
ogy is also supported by the CHO
cell bead implantations performed
previously (Gerlach et al., 2000). No
morphologic abnormalities were ob-
served when cell pellets of two
BMP4-expressing CHO cell lines,
BMP4-6C and BMP4-3D, were im-
planted (nBMP4-6C  11, nBMP4-3D 
19; data not shown).
mDAN Effects on Semicircular
Canals
mDAN-expressing CHO cell pellet
implantations (n  153) altered inner
ear semicircular canal morphology
as early as stages 20 and 26 (n20  8,
87.5% abnormal; n26  17, 64.7% ab-
normal; Fig. 2B,C), the earliest stages
analyzed. Fully developed inner
ears, analyzed at stage 35 or higher,
showed a range of abnormal inner
ear phenotypes (Table 1). Canals
were absent, severely reduced in
size or present with an extra “nub.” In
Figure 2E, all the semicircular canals
are present but the ED/ES is joined to
the SSC. In some cases, a single ca-
nal would be eliminated (Fig. 2F),
whereas in others, multiple canals
were abnormal (Fig. 2G,H). The most
severe SCC phenotype was the
complete absence of all three ca-
nals and ampullae (not shown). No
canals were present without their
ampullae, whereas ampullae could
be present without a canal. The ca-
nal phenotypes were similar to those
observed in ears exposed to noggin
(Gerlach et al., 2000).
The results from anterior (A), cen-
tral (C), posterior (P), dorsal (D), and
ventral (V) implantations are found
in Table 1. Abnormalities were classi-
fied according to the structure(s) af-
fected. For ease of comparison, par-
tial canal truncations, abnormally
shaped canals, and absent canals
were grouped together. Anterior de-
fects were those in which the SSC
and/or the LSC were affected. These
canals are derived from the anterior
region of the developing otocyst.
Posterior defects were those abnor-
malities that affected only the PSC,
which develops from the posterior
region of the developing otocyst.
Anterior–posterior defects were
those affecting the PSC and at least
one of the anteriorly derived canals.
In general, posterior placement of
an mDAN pellet generated posterior
canal phenotypes (n  5, 19%) and
anterior–posterior defects (n  4;
15%). Abnormalities affecting two
canals always affected the PSC and
the LSC, never the PSC and SSC. An-
terior mDAN pellet implantation re-
sulted in anterior defects (n  11;
52%). Instances in which two canals
were abnormal always involved the
SSC and the LSC. There were no in-
stances of both the PSC and the SSC
simultaneously affected either in an-
terior or posterior cell pellet implan-
tations, corresponding with previous
noggin-treated inner ear data
(Gerlach et al., 2000). Central, ven-
tral, and dorsal cell pellet implanta-
tions resulted in canal abnormalities
as well. Central implantations af-
fected each of the three SCC in the
same number, with no double canal
abnormalities. The LSC and SSC
were both affected by ventral pellet
implantations (n  2; 33%), whereas
dorsal implantation resulted in one
anterior defect and one inner ear
with no canals (66%). Of all abnor-
mal canals, 12% were structurally
normal but reduced in size. Extra
nubs were observed on some of the
exposed utricles and ampullae as
well (16%, Table 1).
mDAN Effects on
Endolymphatic Ducts and Sacs
Unlike the noggin-exposed ears,
however, DAN-exposed inner ears
demonstrated endolymphatic duct
and sac malformations. ED and ES
abnormalities were observed in
stage 20 and older embryos (65 of
153, 42.5%; Fig. 2; Table 1). Overall,
60.1% of DAN pellet implantations re-
sulted in some sort of inner ear ab-
normality. Of these inner ear abnor-
malities, 81.3% involved ED and ES
abnormalities. No ED or ES abnor-
malities were ever present in noggin-
exposed inner ears (Gerlach et al.,
2000). In some exposed inner ears,
the ED was partially or completely
merged with the crus (Fig. 2E). The
ED and ES were sometimes smaller
than the control, unexposed inner
ear (data not shown). Other pheno-
types in DAN-exposed inner ears in-
cluded ES nubs that grew toward or
connected to the superior semicir-
cular canal (Fig. 2F). Such nubs are
never found during the course of nor-
mal inner ear development. ED and
ES morphologic abnormalities were
found with or without SCC abnormal-
ities. No connection was observed
























A 1 2 6 3 0 0 0 13 7 21 42 50
C 1 2 2 0 0 0 3 19 2 13 34 62
P 5 1 3 0 0 3 1 15 2 14 40 65
D 0 1 0 0 0 0 1 0 0 1 3 66
V 0 1 1 0 0 0 0 4 1 4 9 55
aDAN pellets were implanted in either the periotic mesenchyme or the center of the otocyst, and the resulting abnormalities
were characterized. A, anterior; Ab, abnormal; C, center; D, dorsal; ED/ES, endolymphatic duct/sac; LSC, lateral semicircular
canal; P, posterior; PSC, posterior semicircular canal; SSC, superior semicircular canal; V, ventral; DAN, differential screening-
selected gene aberrative in neuroblastoma.
222 GERLACH-BANK ET AL.
between an ED or ES abnormality and
a particular SCC malformation.
The effects of exposure to mDAN
in ovo on ED and ES development
are reported in Table 1. In central
mDAN cell pellet implantations,
90.5% of the abnormalities include
ED/ES malformations. Anterior and
posterior pellet implantations al-
tered ED and/or ES morphology in
62% and 57% of the abnormal inner
ears, respectively. ED/ES defects
were also present in the ventral im-
plantations (44%). No ED/ES effects
were observed in the dorsal implan-
tations. In these abnormalities, the
EDs were merged with the crus or
the ES grew toward or into the SSC.
The defects observed did not corre-
spond to the presence or absence
of abnormalities in any particular ca-
nal.
Effectiveness of DAN Exposure
Depends on the Stage
Implanted
To determine the period during
which the ear is most susceptible to
DAN exposure, the surgeries were
grouped by stage and site of im-
plantation (Table 2). Implantations
from stage 11 to stage 19 all gener-
ated at least one inner ear abnor-
mality (n  153). For posterior implan-
tations, a biphasic trend was
observed with  80% of surgeries be-
tween stages 14 and 15 and 18 and
19 exhibiting otic defects. Stages
14–15 were the most affected by an-
terior pellet implantations, whereas
surgeries performed at stages 18–19
were the most effective for centrally
placed pellet implantation-induced
abnormalities. We did not include the
small numbers of ventral and dorsal
DAN implants into the table. Nine ven-
tral DAN implants were performed; of
these, the three performed at stage
16–17 resulted in abnormal inner ears
as did the one done at stage 18. The
one ventral implantation done at
stage 14–15 resulted in a normal inner
ear. Only three (total) dorsal implants
were performed. Those at stages
14/15 and 18 resulted in abnormal in-
ner ears; that at stage 16/17 was nor-
mal.
Some DAN implantations (39.9%)
resulted in normal inner ear pheno-
types (Table 1). Although care was
taken to ensure that the cell pellets
were implanted intact and securely,
the pellets could have been lost or
moved during the normal mecha-
nisms of otic morphogenesis. Further-
more, the inner ear is highly vascu-
larized and some of the secreted
DAN protein could have been
washed away.
Rescue of the DAN Phenotype
by Exogenous BMP4
To determine whether addition of
BMP4-producing cells could rescue
the effect of the DAN cell pellet im-
plantations, BMP4-expressing CHO
cell pellets were coimplanted with
the DAN-expressing CHO cell pellets.
By providing an exogenous source
of BMP4, we sought to saturate the
exogenous DAN activity. Inner ears
were normal in 66% of those em-
bryos coimplanted with CHO-BMP4
and DAN cells (n  34). This is a fre-
quency comparable to that previ-
ously seen for Noggin-expressing cell
bead and BMP4-expressing cell
bead rescue experiments (63%;
Gerlach et al., 2000). Only 42% of the
DAN-expressing cell pellet and un-
transfected CHO cell pellet coim-
plantation controls (n  10) resulted
in normal inner ear phenotypes. This
rate is comparable to the 40% of
ears found to be normal when
mDAN pellets are implanted alone.
The abnormalities observed when
BMP4-expressing cells and DAN-ex-
pressing cells were coimplanted, in-
cluded both canal defects (50% of
abnormal ears) and ED/ES defects
(66% of abnormal ears).
Hair Cell Antigen Expression Is
Not Affected by Exposure to
Exogenous DAN
To analyze the effects of DAN on
otic sensory epithelium, inner ears
exposed to DAN were examined by
using the hair cell-specific antibody
HCA (Bartolami et al., 1991; Good-
year and Richardson, 1992). Hair cell
antigen distribution was unaltered in
unoperated control inner ears as
previously described (Fig. 3A,B;
Gerlach et al., 2000). The distribution
of the hair cell patches and relative
staining levels were altered in the
DAN-exposed inner ears only if the
structures housing the sensory epi-
thelium were abnormal (Fig. 3C,D). If
no inner ear sensory structures were
affected, all vestibular and cochlear
sensory epithelia expressed HCA in a
pattern and at a level similar to con-
trol inner ears. No ectopic HCA ex-
pression was observed in any part of
inner ears that were missing ampul-
lae or within the endolymphatic sac
outgrowths.
Blocking of Endogenous DAN
Protein Expression by Antisense
Oligo Morpholinos Alters Inner
Ear Morphogenesis
The effect of eliminating functional
DAN protein during the develop-
ment of the inner ear was analyzed
by using fluoresceinated antisense
morpholinos designed against our
published chick DAN sequence
(Gerlach-Bank et al., 2002). The mor-
pholinos (MOs) were first injected
and then electroporated into the
otocysts of stage 15, 16, and 17
chick embryos. All morpholino-in-








11–13 40 NA 0
14–15 100 46 80
16–17 39 70.5 56
18–19 44 75 87
aThe percentage of abnormalities observed at each stage of initial plantation
were grouped according to implantation site. Total number of implantations 
128. DAN, differential screening-selected gene aberrative in neuroblastoma; NA,
not available.
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jected otocysts were flushed gently
with PBS before being viewed for flu-
orescein location 24 hr after electro-
poration and the embryo photo-
graphed (Fig. 4A). The extent of
fluorescein within the otocyst varied
from spotted expression in specific
regions/individual cells of the oto-
cyst (Fig. 4B,C) to label throughout
one side or the other of the inner ear
(Fig. 4A). Once photographed, the
embryos were returned to the incu-
bator until stage 35 at which time
the inner ears were removed and
processed for either paint fill analysis
or HCA immunohistochemistry. To
make sure that the MOs were in-
deed being taken up by cells and
not retained in the lumen of the oto-
cyst, in addition to flushing the oto-
cyst before photography, in some
experiments, cryostat sections of in-
jected and electroporated inner
ears were made of unfixed tissue
(because retention of green fluores-
cent protein [GFP] is an issue in fixed
tissue) and photographs were taken
of these inner ears. Cell penetration
in the otocyst was excellent at 2–4 hr
postelectroporation, penetration was
seen in as many as three to four cells
in depth over 10 sections of the oto-
cyst (Fig. 4B,C).
The morphology of inner ears elec-
troporated with the control sense
morpholino (n  7), control DAN-in-
verted antisense morpholino (n  6),
or sham-injected and electropo-
rated (n  21) was completely nor-
mal (Fig. 4F). Inner ears electropo-
rated with the antisense DAN
morpholinos were abnormal (n  9
per stage; 89% abnormal). The ca-
nals of these abnormal inner ears
were frequently much smaller or
Fig. 3. Hair cell antigen (HCA) expression in normal and mDAN (mouse differential screening-selected gene aberrative in neuroblas-
toma) -exposed inner ears. A: Medial view of a normal stage 36 inner ear with normal HCA expression in the sensory epithelium. The
macula neglecta is present but not visible. B: Paint fill of the ear in A demonstrating that all the canals and ampullae are present. C: A
stage 36 mDAN-exposed inner ear with normal HCA expression. No canals were missing; however, the endolymphatic duct (severed
during analysis) had an extraneous nub. D: Paint fill of the ear in C. bp, basilar papilla; l, lagena; lc, lateral crista; LSC, lateral semicircular
canal; mn, macula neglecta; ms, macula saculi; mu, macula utriculi; pc, posterior crista; PSC, posterior semicircular canal; sc, superior
crista; SSC, superior semicircular canal. Scale bars  100 m in A (applies to B,C).
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truncated (50% abnormal), whereas
the endolymphatic sacs were
grossly enlarged (62.5% abnormal;
Fig. 4D,E). All of the inner ears in-
cluded in the analysis demonstrate
some number of fluorescent cells.
To determine whether the sensory
epithelium was affected by electro-
poration of the antisense DAN mor-
pholinos, the electroporated ears
were analyzed for HCA expression.
In uninjected (n  6) and control in-
Fig. 4. DAN (differential screening-selected gene aberrative in neuroblastoma) morpholino-electroporated inner ear analyzed by paint
fill. A: Stage 20 chick embryo 24 hr after in ovo electroporation with DAN antisense-fluoresceinated morpholino (MO). The entire inner ear
demonstrates fluorescence. B,C: View of two adjacent sections of cryosectioned (but not fixed) stage 16 inner ear 4 hr after injection and
electroporation of fluorescein-conjugated DAN sense MO. The electrodes were positioned so that the morpholino was electroporated into
the lateral (outside) epithelium of the otocyst. Note that the fluorescent MO is located in different individual cells in the two adjacent
sections, with those in (C) closer to the lumen. Medial is to the left, lateral is to the right, dorsal is to the top, and ventral to the bottom of
the photographs in A–C, which were taken at 20 original magnification. Insert in B: Brightfield view of the otocyst seen at 4 original
magnification. D,E: Ventral view of stage 36 paint-filled inner ears. Ventral is to the top. The right inner ear was electroporated with
antisense DAN morpholinos. The superior semicircular canal (SSC) is truncated and the endolymphatic sac (es) is enlarged. F: Ventral
view of stage 32 paint-filled inner ears. The right inner ear was electroporated with control inverted antisense DAN morpholinos. cd,
cochlear duct; lsc, lateral semicircular canal; psc, posterior semicircular canal. Note that the ear morphology is normal in the electro-
porated inner ear. Scale bar  100 m in D (applies to D–F).
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ner ears (n  3), HCA expression was
normal in all of the sensory epithelia
(data not shown, see Fig. 3A). The
HCA pattern observed in antisense
DAN morpholino-electroporated in-
ner ears (n  13) was unaltered
(data not shown). No ectopic or ex-
panded regions of HCA expression
was observed in the sensory epithe-
lium or in the enlarged ED/ES.
DISCUSSION
DAN is a member of a recently de-
scribed cysteine knot protein family,
including cerberus and gremlin (Hsu
et al., 1998; Stanley et al., 1998;
Pearce et al., 1999). DAN is a se-
creted protein with tumor suppressor
activity that exhibits weak BMP an-
tagonist activity in vitro and in vivo
(Ozaki and Sakiyama, 1994; Ozaki et
al., 1995; Hsu et al., 1998; Stanley et
al., 1998; Dionne et al., 2001). Expo-
sure to ectopic DAN protein in Xeno-
pus animal cap assays induces an-
terior neural tissue and endoderm,
suggesting a block in the BMP signal-
ing cascade (Stanley et al., 1998).
Biochemical analysis has demon-
strated that DAN binds directly to
BMP2 and interferes with BMP4 activ-
ity, although weakly compared with
other antagonists (Hsu et al., 1998;
Pearce et al., 1999). Direct binding
of DAN with BMP4 or BMP2 under
physiological conditions has not yet
been shown (Dionne et al., 2001).
We recently have described DAN
message expression in the develop-
ing chick embryo (Gerlach-Bank et
al., 2002). Expression is found in the
developing somites, intermediate
mesoderm of the nephritic duct,
eye, branchial arches, and limb
buds. DAN is also expressed in the
developing chick otocyst, where it is
restricted to the medial otic epithe-
lium through stage 25. As the vestib-
ular and cochlear structures differ-
entiate after this stage, DAN mRNA
expression remains restricted to the
endolymphatic duct and sac, the
medial surface of the utricular–sac-
cular–cochlear junction, and the
cochlea. The medial otic expression
of DAN at stage 16 overlaps to some
degree with the expression of BMP7,
which is located throughout the en-
tire medial otic epithelium except
for a small ventral region (Oh et al.,
1996; Wu and Oh, 1996). The poten-
tial interaction between BMP7 and
DAN has not been investigated in
this or other published studies. BMP4
and BMP5 focal expression is found
at the anterior and posterior edges
of the otocyst (Oh et al., 1996; Wu
and Oh, 1996).
Many studies have shown that
BMP4 is a secreted protein capable
of acting over distances as a mor-
phogen in multiple species (Harland,
1994; Re’em-Kalma et al., 1995;
Dosch et al., 1997; Gerlach et al.,
2000; for reviews of BMP4 activity,
see Hogan, 1996; Hild et al., 2000). It
is possible that DAN may act as an
additional antagonist of BMP activ-
ity, complementing that of noggin,
but that DAN has a specific func-
tional role during inner ear develop-
ment separate from that of its inhibi-
tion of BMPs. The experiments in this
study were directed at ascertaining
the role of DAN in chick otic devel-
opment.
In an attempt to determine
whether DAN could function in the
developing otocyst as a BMP antag-
onist, mDAN-expressing cell pellets
were implanted into the otocyst or
the periotic mesenchyme, present-
ing the inner ear with an exogenous
source of DAN protein. If DAN acts
as an effective BMP antagonist in
vivo, exogenous DAN would be ex-
pected to bind to any BMP present,
thereby blocking the BMP’s ability to
bind its receptors. The resulting otic
phenotype would be expected to
be similar to that found previously
when noggin-producing cells were
implanted into the periotic mesen-
chyme (Gerlach et al., 2000). In gen-
eral, treatment of the inner ear with
DAN did mimic treatment of the in-
ner ear with noggin. Posterior DAN
pellet implantation resulted in PSC
defects while anterior pellet implan-
tation resulted in defects of the an-
teriorly derived canals, the LSC and
SSC. As shown in Table 3, these ca-
nal phenotypes are similar to those
previously reported when noggin-
expressing cells were implanted into
the posterior and anterior periotic
mesenchyme, although the fre-
quency of the DAN SCC abnormali-
ties is lower (72% for noggin, Gerlach
et al., 2000; 60.1% for DAN). Because
DAN is reportedly a weaker BMP4
antagonist than Noggin, one would
expect a lesser affect on BMP down-
stream events. This expectation is
supported by the requirement for
implantation of DAN cell pellets con-
taining over 1,000 cells (at implant)
to generate inner ear canal pheno-
types similar to those seen when
noggin beads carrying an average
of 14 cells are implanted (Gerlach et
al., 2000). Noggin beads produced
0.84  0.11 pg of protein per 24 hr
(Gerlach et al., 2000), whereas DAN
pellets produced approximately 95
ng per 24 hr.
Implantation of DAN-expressing
pellets produced canal abnormali-
ties similar to those seen in noggin
implantation studies and were res-
cued by coimplantation with BMP4-
expressing cell pellets, supporting
the idea that DAN functions at least
in part to block BMP activity within
the inner ear. However, central im-
plantation of DAN pellets produced
primarily anterior defects or com-
plete elimination of the semicircular
canals. This finding is not consistent
with the data from noggin implanta-
tion experiments. Central implanta-
tion of noggin-producing cells did
not generate any abnormal inner
ear phenotype in previous work (Ta-
ble 3; Gerlach et al., 2000). Abnor-
mal cochlear duct morphology was
not observed in the DAN-exposed
inner ears, whereas shorter and
thicker cochleae were observed in
Noggin-exposed ears. The fre-
quency of dorsal implant abnormal-
ities was higher in DAN implants than
in noggin implants (Table 3).
Furthermore, exogenous DAN ex-
posure produced ED and ES abnor-
malities that were never observed in
noggin-exposed inner ears. Expo-
sure of inner ears to exogenous DAN
resulted in a range of ED and ES ab-
normalities, from the growth of a nub
toward the SSC and crus of the inner
ear to the more severe merger of
the ES/ED with the crus or SSC.
Smaller ED and ES were also ob-
served. The majority of ED/ES abnor-
malities resulted from central DAN
pellet implantation within the oto-
cyst, which may be a result of a
larger portion of the otocyst being
exposed to exogenous DAN in these
implants or more DAN protein being
presented to otic epithelial cells
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competent to interact with the pro-
tein.
The ability of DAN to affect ED/ES
outgrowth and morphogenesis as
seen in the DAN pellet assays was
supported by the ED/ES phenotypes
observed in the inner ears of chicks
whose otocysts were electropo-
rated in ovo with antisense DAN
morpholinos. The resulting inner ears
demonstrated grossly enlarged
ED/ES (62.5%) compared with the
left control and standard control
morpholino-exposed inner ears. Fur-
thermore, in the experimental ears,
the semicircular canals were slightly
reduced in size or truncated (50%). A
combination of reduced SCC size
and increased ED/ES growth was
observed in some morpholino-in-
jected ears (25% of those that were
abnormal). This finding suggests a
role for DAN in regulating the pro-
portionment of the medial otic epi-
thelium into the future endolym-
phatic structures and the remainder
of the inner ear. DAN may affect this
result by disrupting the BMP feed-
back loop in the otocyst or by alter-
ing signaling pathways, which do
not involve BMPs. For example, DAN
is a member of the cerberus family,
which is known to affect both Nodal
and Wnt signaling activity. DAN may
be acting in the inner ear to alter
both BMP signaling as well as that of
Nodal or Wnt. The antisense mor-
pholino experiments provide an in-
triguing indication that DAN func-
tions in the distribution of tissue or
cells into the ED/ES and other medi-
ally derived structures, but there are
certain caveats that require further
exploration of this hypothesis. An an-
tibody to DAN protein, which is pres-
ently unavailable, would allow us to
ascertain to what extent the protein
itself is being produced in MO-
treated inner ear tissues. It is clear
that only in the best of cases do we
affect all DAN-producing cells (Fig.
4). A second series of rescue exper-
iments, in which MO electroporation
could be closely followed by DAN
cell pellet implants in the same ear
might also provide support for this
hypothesis. However, we have
found that an inordinately large
number of embryos would have to
be treated in this way, followed by
assessment of MO distribution at 24
hr. Morbidity in such doubly oper-
ated embryos, which would require
two successive and closely spaced
invasive procedures is very high (on
the order of 90%). However, that the
MO treatments have effects only on
the inner ear and not the surround-
ing tissues or hindbrain and that MO
treatment produces the obverse of
the gain-of-function phenotype
seen when DAN cell pellets are im-
planted encourages us to persist in
the exploration of DAN’s role in me-
dial epithelial partitioning.
BMP4 has been shown to presage
sensory epithelium differentiation
(Wu and Oh, 1996). To determine
whether the potential DAN–BMP4 in-
teraction affected this tissue, an
anti-HCA antibody was used as a
sensory epithelial marker and as-
sayed in DAN-exposed and DAN
morpholino-injected inner ears. HCA
expression in the DAN-exposed inner
ears was absent only if the otic struc-
ture housing the sensory epithelium
was eliminated. This finding is consis-
tent with HCA expression in noggin-
exposed inner ears (Gerlach et al.,
2000) and supports the hypothesis
that DAN acts, at least partially,
through BMPs. No ectopic or super-
numerary cells with HCA staining
were apparent. It is possible that
DAN antagonism of BMP4, which is
weaker than that of noggin, was in-
sufficient to disrupt patterning of the
sensory epithelium or that the DAN
pellets were implanted after the sen-
sory epithelium had already been
patterned. Otocysts electroporated
with the antisense DAN morpholino
and, therefore, not able to translate
DAN protein, also expressed HCA in
TABLE 3. Comparison of DAN and Noggin Implant Resultsa
Surgery
Number of




DAN 42 52 4.70 0.00 0 62 50
Noggin 39 83 8.50 8.50 4.30 0 59
Central
DAN 34 19 4.70 14.30 0 90.50 62
Noggin 0 0 0 0 0 0 0
Posterior
DAN 40 15 19 15 0 57.70 65
Noggin 39 0 57 43 25 0 71.80
Dorsal
DAN 3 50 0 50 0 0 66
Noggin 18 57 0 43 0 0 38.90
Ventral
DAN 9 40 0 0 0 80 55
Noggin 26 33 0 67 54.20 0 50
aThe abnormalities observed upon implantation of DAN pellets and Noggin beads were compared based upon implantation
site. The Noggin implant data is from Gerlach et al. (2000). A, anterior; AP, anterior–posterior; CD, cochlear duct; ED,
endolymphatic duct; ES, endolymphatic sac; P, posterior; DAN, differential screening-selected gene aberrative in
neuroblastoma.
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the appropriate locations as long as
the structure housing the epithelium
was present. No ectopic HCA ex-
pression was found in any of the ab-
normal ED/ES of the DAN-exposed or
functionally DAN-negative inner
ears. Therefore, DAN does not ap-
pear to affect sensory epithelium
development in these inner ears.
Based on the data presented, we
propose that DAN may have two
functions in the development of the
inner ear. First, DAN may act to in-
hibit BMP signaling by binding it and
inhibiting its signaling. This possibility is
supported by the similarities be-
tween DAN-exposed inner ear phe-
notypes, the noggin-exposed inner-
ear phenotypes (Gerlach et al.,
2000) and the chordin cell pellet im-
plant phenotypes (unpublished
data). The known differences in the
strength of DAN and Noggin’s an-
tagonism of BMP4 can also explain
why DAN treatment causes abnor-
malities in statistically fewer cases
than does noggin (Table 3). Colocal-
ization of BMP proteins and DAN has
not been confirmed, because there
are no antibodies available for ei-
ther protein’s immunohistochemical
analysis; however, the mRNA expres-
sion patterns of DAN and the BMPs in
the medial otocyst suggests that
DAN may act with other antagonists
in the otocyst to sequester BMP ac-
tivity. Second, our data suggests
that DAN functions to regulate the
partitioning of the medial otic epi-
thelium into the endolymphatic tis-
sue and the remainder of the struc-
tures derived from the medial otic
epithelium of the inner ear.
While the absence of or reduction
in functional DAN protein increases
the amount of tissue contained in
the ED, the presence of exogenous
DAN protein serves to prevent the
normally observed complete sepa-
ration of the ED/ES from the medial
otocyst, resulting in connections with
the crus and ventral portion of the
SSC. DAN may be achieving this ef-
fect through interactions with BMPs
in ovo. Alternatively, DAN may act
through as yet unidentified factors to
direct the separation of the ED/ES
from the remainder of the medial
otocyst. Such a mechanism is sug-
gested by the absence of ED/ES ab-
normalities in noggin-exposed inner
ears.
Factors, other than BMPs, with
which DAN could interact to effect
the ED/ES partitioning are presently
unknown. Biochemical assays have
demonstrated the ability of DAN to
bind members of the GDF5/6/7 fam-
ily (Dionne et al., 2001). Currently, it is
unknown whether these factors are
expressed in the developing inner
ear. The protein DA41, a DAN bind-
ing protein that interacts with the
EGF1-like factor S(1-5), may affect
DAN signaling in the ED/ES but ex-
pression of DA41 has not yet been
described in the otocyst (Ozaki et
al., 1997b). Although Pax2 is known
to be expressed in the developing
ED/ES (Hutson et al., 1999), no inter-
actions between Pax2 and DAN
have been identified. As a member
of the cerberus family, DAN might
also function to alter Nodal and/ or
Wnt signaling. Such an interaction
has not yet been shown biochemi-
cally, however. Future studies re-
quire the identification of DAN-inter-
acting proteins to elucidate the
mechanism by which DAN is in-
volved in the partitioning of the me-
dial otocyst between the endolym-
phatic structures and the remainder
of the inner ear.
EXPERIMENTAL PROCEDURES
Preparation of DNA Constructs
The mouse DAN sequence was am-
plified by using the following primers
(forward: 5-ACAATGCTTTGGGTC-
CTGGT-3; reverse: 5-GTCCTCAGC-
CCCCTCTTC-3) and subcloned in
frame with the V5 epitope tag of the
TopoTA pcDNA3.1()-V5 vector (In-
vitrogen). Orientation of the sub-
cloned product was confirmed by
sequencing. A full-length mouse
BMP4 cDNA that was obtained from
Drs. Deborah Thompson and Ron
Koenig (University of Michigan)
(Thompson et al., 2003) was sub-
cloned into the pcDNA3.1() vector
(Invitrogen), which contained an HA
epitope tag and subsequently trans-
fected into CHO cells for use in the
“rescue” experiments.
In Situ Hybridization and Probe
Syntheses
In situ hybridization and probe syn-
theses were performed as previously
described (Gerlach-Bank et al.,
2002). Embryos were collected and
fixed in 4% paraformaldehyde (PFA),
cryoprotected in 20% sucrose and
embedded in OCT (Miles). The
12-m sections were placed on Su-
perfrost plus slides (VWR) and label-
ing was detected by alkaline phos-
phatase.
Cell Transfection and Culture
The mDAN and BMP4 constructs
were individually transfected into
CHO cells using the Transfast Trans-
fection Kit (Promega). Stable clones
were selected by using G418
(Gibco-BRL). Production of V5-
tagged mDAN-expressing clones
was determined and quantified by
Western blotting (data not shown).
Expression of mBMP4 was confirmed
by Western blotting using antibodies
against the HA epitope (Invitrogen).
CHO and noggin-expressing CHO
cells were grown as previously de-
scribed (Smith et al., 1993, Gerlach
et al., 2000), whereas the stable
mDAN-expressing or mBMP4-ex-
pressing clones were cultured in
CHO media containing 0.8 mg/ml
G418. mDAN-expressing CHO cells,
mBMP4-expressing CHO cells, and
untransfected CHO cells were
trypsinized, and 1,000-cell aliquots
were used to make hanging drop-
cultured cell pellets. The pellets were
cultured overnight before implanta-
tion.
To determine the average num-
ber of mDAN-expressing CHO cells in
each pellet after overnight culture,
three groups of 48 cultured pellets
were collected. The pooled sample
was trypsinized with shaking for 20
min at 37°C. The cells were then
counted in a Beckman Coulter Z1
Coulter Counter in triplicate (n  9)
to determine the number of cells per
cultured pellet.
Western Blots
Western blots were used to quantify
V5 epitope tagged mDAN expres-
sion in transfected CHO cells and
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were performed according to the
protocol suggested for use with the
anti–V5-HRP antibody (Invitrogen).
mDAN-transfected CHO cells were
cultured for four days in serum-free
CHO medium (CHO-SFII, GibcoBRL).
The supernatants were collected,
and serial dilutions were made for
use in Western blot assays. The cells
contributing to the supernatant
were trypsinized and counted with a
hemocytometer. Supernatants from
untransformed CHO cells served as
negative controls while the Positope
peptide (Invitrogen), containing the
V5 epitope, was used as the positive
control. Chemiluminescent detec-
tion was performed by using an ECL
kit (Amersham) and analyzed.
Surgical Pellet Implantations
Fertilized White Leghorn chicken
eggs were obtained from the Bilbie
Aviaries, Ann Arbor, MI, and incu-
bated at 37  1°C. All pellet implants
were performed on embryos be-
tween stages 11 and 19 (all staging
according to Hamburger and Ham-
ilton, 1951). The eggs were win-
dowed and prepared as previously
described (Gardner and Barald,
1991; Gerlach et al., 2000). A slit was
made in the otic mesenchyme or
the center of the otocyst, and a cell
pellet was mouth-pipetted into the
opening. The cell pellets were
dipped briefly in a neutral red solu-
tion before implantation to visualize
the pellet as it was inserted. mDAN-
expressing cells, BMP4-expressing
cells, or untransfected CHO cells
were implanted in dorsal, ventral,
anterior, posterior, or central loca-
tions (see Fig. 2). For rescue or rescue
control experiments, mDAN-express-
ing cell pellets were implanted with
either BMP4-expressing or untrans-
fected CHO cell pellets. All implan-
tations were performed on the right
inner ear. The left inner ear served as
the internal, unmanipulated control.
After implantation, the embryos
were incubated until the desired
stage. The embryos were then har-
vested and fixed in Bodian’s fixative
(75% 95% ETOH, 5% formaldehyde,
5% glacial acetic acid, 15% MilliQ
water/v/v/v/v/) for paint fill analysis
or in 4% paraformaldehyde for im-
munohistochemistry as previously
described (Gerlach et al., 2000).
Paint Injections
To more easily visualize the inner
ear’s morphology, a solution of 1%
white semigloss paint (Benjamin
Moore) in methyl salicylate was in-
jected through the cochlear duct or
utricle as previously described (Mar-
tin and Swanson, 1993; Bissonnette




The inner ears from stage 35–36 im-
planted or electroporated embryos
were excised and prepared for im-
munohistochemistry as previously
described (Wu et al., 1998; Gerlach
et al., 2000). The ears were stained in
a 1:1,000 dilution of an antibody spe-
cific for a 275-kDa HCA kindly pro-
vided by Dr. Guy Richardson, Sussex
University (Bartolami et al., 1991;
Goodyear and Richardson, 1992)
and post-fixed in 4% paraformalde-
hyde.
In Ovo Electroporation of
Morpholino Oligonucleotides
In ovo electroporation was carried
out as described by Kos et al. (2001).
Briefly, eggs were windowed as for
pellet implantation, and the vitelline
membranes were removed. A
1-g/ml solution of GFP–plasmid or a
500-M solution of the DAN anti-
sense morpholino, the control in-
verted DAN antisense morpholino, or
the control sense morpholino stan-
dards obtained from GeneTools
(Corvalis, OR) was mouth-pipetted
into the otocyst. A GFP expression
construct (Clontech) was initially
used to demonstrate that the elec-
troporation technology was working
and that the cells could make GFP
up to 48 hr later. GFP expression con-
structs were not used with morpholi-
nos in the experiments described in
this report. The fluoresceinated stan-
dard control sequence was 5-
CCTCTTACCTCAGTTACAATTTATA-3.
The fluoresceinated DAN antisense
morpholino was 5-CACCCA-
GGAGACGGCGGGCACATCC-3.
The fluoresceinated DAN inverted
antisense control morpholino was
5-CCTACACGGGCGGCAGAG-
GACCCAC-3. The plasmid and
morpholinos were dissolved in vital
dye (1 PBS with blue food color-
ing) to facilitate visualization. Each
morpholino was fluorescein-conju-
gated to aid in confirming in ovo
uptake. The 1-mm gold plated
electrodes (BTX) were placed 1
mm away from each side of the
embryo with the otocyst centered
between them, and two drops of
Locke’s solution were placed over
the embryos. Five 100-msec pulses
of 12 V were applied (ECM 830,
BTX) directing the morpholinos to
the medial region of the otocyst.
The inner ears were visualized 24 hr
postelectroporation under a dis-
secting microscope, each MO-
injected and electroporated ear
was punctured and gently flushed
with PBS to ensure that no trapping
of MO/GFP had occurred and the
fluorescein expression pattern sub-
sequently recorded (Fig. 4A). The
embryo was incubated until stage
35–36, at which point the ear was
analyzed by paint injection (Fig.
4D–F) or immunohistochemistry. To
determine whether the MOs were
being successfully taken up by
cells, we also performed a series of
experiments in which the fluoresce-
in-conjugated sense MO was in-
jected into stage 16 otocysts and
was then electroporated toward
the lateral (external) otic wall.
These embryos were cryosectioned
without fixation 2– 4 hr after electro-
poration to determine the cellular
location of the labeled MO (Fig.
4B,C).
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